a Department of Medical Affairs , GlaxoSmithKline , Rockville , MD , USA.
b Department of Translational Science , GlaxoSmithKline , Siena , Italy.
Ann Med. 2018 May;50(3):181-192. doi: 10.1080/07853890.2017.1417632. Epub 2018 Jan 16.
Life-long primary prevention interventions beginning and continuing throughout an individual's lifetime are increasingly seen as key to meeting the global healthcare challenges that accompany demographic changes - a concept referred to as "Healthy aging". In this perspective, vaccination is seen as part of a triad, together with healthy diet and exercise. Current adult vaccine coverage is lower than target vaccination rates in most developed countries, and so vaccine preventable diseases continue to present a substantial burden on health and healthcare resources, especially in older individuals. In part, this is due to lack of knowledge and understanding of the benefits of vaccination, inconsistent recommendations by providers and uncertainties about cost benefits. However, lower vaccine effectiveness in older adults plays a part, and new vaccines with novel characteristics to improve effectiveness in older adults are required. A life-course immunization approach to ensure optimal vaccine uptake across adults of all ages can be expected to reduce morbidity and mortality in later life. To achieve this, greater emphasis on public and healthcare provider education is necessary, based on appropriate economic analyses that demonstrate the overall value of vaccination. This article introduces the technical, economic, political and demographic issues that make establishing effective adult vaccination programs such a difficult, but pressing issue, and outlines some of the steps that are now being taken to address them. Key messages Life-long preventive activities that start and continue throughout life are essential, especially as the world's population is "getting older". This "Healthy aging" approach includes not only healthy diet and physical exercise; vaccination is critical in reducing some infectious diseases and their complications. Many adults, especially older adults (who have lower immunity than younger people) develop infections such as influenza and shingles that could potentially be prevented through vaccination. This review provides a perspective on the challenges in delivering a life-course immunization program. While some vaccines are less effective in older people, newer vaccines have been developed which provide stronger and longer protection in older patients than standard existing vaccines. However, the benefits of vaccination can only be realized if the vaccines are recommended and used. For that purpose, greater education of patients and their healthcare providers is necessary. Better knowledge of vaccines and making sure that all adults are up to date with all their recommended vaccines is an essential part of "Healthy aging". This should prevent not only vaccine-preventable diseases but also reduce the risk of complications in later life.
终身初级预防干预措施从个体的一生开始并持续进行,被越来越多地视为应对伴随人口变化而来的全球医疗保健挑战的关键,这一概念被称为“健康老龄化”。从这个角度来看,疫苗接种被视为健康饮食和锻炼的三位一体的一部分。在大多数发达国家,当前成人疫苗接种覆盖率低于目标接种率,因此疫苗可预防疾病仍然对健康和医疗保健资源构成重大负担,尤其是在老年人中。部分原因是缺乏对疫苗益处的了解和认识,提供者的建议不一致,以及对成本效益的不确定性。然而,老年人的疫苗效力较低也是一个因素,需要具有提高老年人效力的新特点的新型疫苗。终身免疫接种方法可确保所有年龄段的成年人最佳疫苗接种率,预计可降低晚年的发病率和死亡率。为了实现这一目标,需要加强对公众和医疗保健提供者的教育,同时进行适当的经济分析,以证明疫苗接种的总体价值。本文介绍了在建立有效的成人疫苗接种计划方面面临的技术、经济、政治和人口统计问题,这些问题使得这一问题变得如此困难,但又迫在眉睫,并概述了目前为解决这些问题而采取的一些步骤。主要信息
从个体的一生开始并持续进行的终身预防活动至关重要,尤其是因为世界人口正在“老龄化”。这种“健康老龄化”方法不仅包括健康饮食和体育锻炼;疫苗接种在减少某些传染病及其并发症方面至关重要。
许多成年人,尤其是老年人(其免疫力低于年轻人)会患上流感和带状疱疹等感染,如果通过疫苗接种可以预防这些感染。
本综述提供了提供终身免疫接种计划方面的挑战视角。虽然一些疫苗在老年人中的效果较差,但已经开发出了一些新疫苗,这些疫苗在老年患者中的效果更强、持续时间更长,比标准现有疫苗的效果更好。
然而,只有在推荐和使用疫苗的情况下,才能实现疫苗接种的好处。为此,需要对患者及其医疗保健提供者进行更多的教育。
更好地了解疫苗并确保所有成年人都已接种所有推荐的疫苗,是“健康老龄化”的重要组成部分。这不仅可以预防疫苗可预防的疾病,还可以降低晚年生活并发症的风险。